« Previous
Next »
Titles
- Safety testing of drug metabolites1
- Self-monitoring blood glucose test systems for over-the-counter use: guidance for industry and Food and Drug Administration staff1
- Slowly progressive, low-prevalence rare diseases with substrate deposition that result from single enzyme defects: providing evidence of effectiveness for replacement or corrective therapies1
- State of Interoperability among U.S. non-federal acute care hospitals in 20181
- Statistical considerations for clinical trials during the COVID-19 public health emergency1
- Submission of plans for cigarette packages and cigarette advertisements (revised)1
- Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: guidance for industry and Food and Drug Administration staff1